# Haleon

> Haleon is the world's largest standalone consumer-health company, spun out of GSK in 2022 with a portfolio of everyday-health brands - Sensodyne, Panadol, Advil, Centrum, Voltaren, Otrivin and more - sold in around 170 markets. It sits in the aisle between the pharmacy and the supermarket, organised around five categories: oral health, pain relief, respiratory health, digestive health, and vitamins, minerals and supplements. The pitch is simple: help people manage more of their own health, at scale, with products they already trust.

- **Founded:** 2022
- **Headquarters:** Weybridge, United Kingdom
- **Founders:** Brian McNamara (Founding Chief Executive Officer), Manvinder Singh Banga (Chairman)
- **Team size:** ~24,000-25,000 employees
- **Products:** Sensodyne / parodontax / Polident (Oral Health), Panadol / Advil / Voltaren (Pain Relief), Centrum / Emergen-C (Vitamins, Minerals & Supplements), Theraflu / Otrivin / Flonase (Respiratory Health), Tums / ENO (Digestive Health)
- **Notable:** Largest standalone consumer-health company in the world at launch (2022)., Biggest London Stock Exchange listing in over a decade at demerger., Reported £11.2bn revenue and ~£2.2bn operating profit in FY2024.

## Products & services

- **Sensodyne / parodontax / Polident (Oral Health)** — Therapeutic oral-care brands for sensitivity, gum health and denture care; Haleon's largest and fastest-growing category.
- **Panadol / Advil / Voltaren (Pain Relief)** — Over-the-counter analgesics and topical pain-relief for headaches, fever, joint and muscle pain.
- **Centrum / Emergen-C (Vitamins, Minerals & Supplements)** — Multivitamins and supplements aimed at everyday wellness and immune support.
- **Theraflu / Otrivin / Flonase (Respiratory Health)** — Cold, flu and allergy relief, decongestants and nasal sprays.
- **Tums / ENO (Digestive Health)** — Antacids and digestive-relief products for heartburn and indigestion.
- **ChapStick** — Lip-care brand within the broader everyday-health portfolio.

## Achievements

- Largest standalone consumer-health company in the world at launch (2022).
- Biggest London Stock Exchange listing in over a decade at demerger.
- Reported £11.2bn revenue and ~£2.2bn operating profit in FY2024.
- Dual-listed on the London Stock Exchange and NYSE under ticker HLN.
- Portfolio of category-leading 'power brands' including Sensodyne, Panadol, Advil, Centrum and Voltaren.

## Latest updates

- **2025-10** — Haleon's Irish sales division reported growing profits, underscoring steady performance in core European markets.
- **2024-12** — Reported full-year 2024 revenue of £11.2bn with organic growth led by Oral Health and VMS categories.
- **2024-01** — Sensodyne Clinical White rolled out across eight markets including the US, UK and Turkey.

## Links

- Website: https://haleon.com
- LinkedIn: https://www.linkedin.com/company/haleon
- Twitter/X: https://twitter.com/HALEON_health
- YouTube: https://www.youtube.com/@haleon
- Instagram: https://www.instagram.com/haleon
- Facebook: https://facebook.com/profile.php?id=100083295823330

---

Profile page: https://yespress.io/haleon
Published by YesPress — https://yespress.io
Last updated: 2026-08-11